LIMR’s Institutional Biosafety program oversees research involving recombinant DNA, pathogenic organisms, and/or human or non-human primate-derived materials (cell lines, tissues, fluid, etc.). Additionally, the Committee oversees all projects involving infectious agents (RG-2 and 3) and certain toxins that are on the CDC Select agents list.

It is the responsibility of the Investigator to submit the proposed research to the LIMR Institutional Biosafety Committee (LIMR IBC) for approval before the research has begun. A list of meeting dates and deadlines is below. You may not start your research until your protocol has been reviewed and approved by the IBC. Researchers using complete and submit the forms listed below and obtain approval from the LIMR IBC prior to starting any work on the project(s). NOTE: All submissions should be sent to [email protected].

For additional information:

LIMR IBC Meeting Dates

The bi-monthly LIMR IBC Meetings are all virtual via TEAMS and begin at 2PM.

TEAMS Link: Click here to join the meeting.

  • March 8, 2022
  • May 10, 2022
  • July 12, 2022
  • September 13, 2022
  • November 8, 2022